PARIS/LONDON, April 28 (Reuters) – French pharmaceuticals
group Sanofi said on Thursday it had made an offer to
buy U.S. cancer treatment firm Medivation in a deal worth about
$9.3 billion, marking…
The post UPDATE 1-Sanofi bids $9.3 bln for U.S. cancer drug firm Medivation appeared first on NASDAQ.